NCLEX-PN
Hematologic System NCLEX Questions Questions
Extract:
Question 1 of 5
Which clinical manifestation of Stage I non-Hodgkin’s lymphoma would the nurse expect to find when assessing the client?
Correct Answer: C
Rationale: Stage I NHL is often asymptomatic (
C), with localized node involvement. Enlarged nodes (
A) are later, LUQ tenderness (
B) suggests spleen, and B-cell elevation (
D) is lab-based, not clinical.
Question 2 of 5
The client is diagnosed with Hodgkin’s disease. Which data are diagnostic for Hodgkin’s disease?
Correct Answer: C
Rationale: Reed-Sternberg cells on biopsy (
C) are diagnostic for Hodgkin’s. Night sweats/fever (
A) and weight loss/nodes (
D) are supportive, and cavitation (
B) suggests TB.
Question 3 of 5
The nurse assesses the client diagnosed with acute myeloid leukemia. Which finding should be the nurse’s priority for implementing interventions?
Correct Answer: A
Rationale: A. Pain control is priority. The altered VS (other than temperature) could be related to pain. B. Weakness and fatigue are due to anemia and also the disease process. It is important to allow rest, but if pain is not controlled the client may not be able to rest. C. The temperature warrants further monitoring because it could indicate a developing infection; the other VS may decrease if pain is controlled. D. Ecchymosis and petechiae are associated with low platelet counts. The nurse should check the laboratory report for the platelet level, but this is an assessment and not an intervention.
Question 4 of 5
The client diagnosed with sickle cell anemia is experiencing a vaso-occlusive sickle cell crisis secondary to an infection. Which medical treatment should the nurse anticipate the HCP ordering for the client?
Correct Answer: C
Rationale: Hydration with IV fluids (
C) prevents sickling in vaso-occlusive crisis. Meperidine (
A) is avoided (risks seizures), isolation (
B) is excessive, and Foley (
D) is unnecessary.
Question 5 of 5
The client undergoing intensive chemotherapy for Hodgkin’s lymphoma (HL) is hospitalized with fever and depressed immune system functioning. The nurse is administering filgrastim subcutaneously daily. Which laboratory value should the nurse monitor to determine the medication’s effectiveness?
Correct Answer: C
Rationale: A. Epoetin alfa, not filgrastim, is used to treat anemia that is associated with cancer, and its effectiveness would be reflected in the Hgb values. B. Oprelvekin (Neumega), not filgrastim, enhances the synthesis of platelets. C. The nurse should monitor the ANC. Filgrastim (Neupogen) is usually discontinued when the client’s absolute neutrophil count (AN
C) is above 1000 cells/mm3. Filgrastim, a granulocyte colony-stimulating factor (G-CSF) analog, is used to stimulate the proliferation and differentiation of granulocytes and treat neutropenia. D. Reed-Sternberg cells are found in lymph node biopsy cells and are indicative of Hodgkin’s lymphoma; they are not monitored to determine the effectiveness of filgrastim, which is used to treat neutropenia.